HIV and ID Observations Blog

Drug Prior Authorizations Are a Very Blunt Tool for Cost Containment — And They’re Annoying Free

Dr. Paul Sax discusses those dreaded forms — insurance prior authorizations — and what impact they have on HIV clinical care.

Drug Watch


The FDA has approved the integrase inhibitor dolutegravir for treatment of HIV infection, in combination with other antiretrovirals.